May 15, 2014 13:00 UTC

EuroMedtech™ 2014 Reports an 82% Increase in Licensable Assets and Technologies Brought to Partner

EuroMedtech 2014

ZUG, Switzerland & LINZ, Austria--(BUSINESS WIRE)-- The sixth annual EuroMedtech™ partnering conference, held May 7–8, 2014, wrapped up in Linz, Austria last week. The event reported an 82% increase in licensing opportunities at the event, indicating a surge in medtech innovation and the increasing role of collaboration in medtech industry business strategies.

EuroMedtech(TM) 2014 (Photo: Business Wire)

EuroMedtech(TM) 2014 (Photo: Business Wire)

“The event was buzzing with activity this year, with substantial increases in both licensing opportunities and partnering meetings,” said Florian Schoenhammer, Group Managing Director, EBD Group. “We have consistently received input from medtech industry leaders that partnering is extremely valuable to them. The numbers this year are the strongest indicator we have seen that the industry is evolving, and partnering has emerged as the major business strategy for bringing medical devices and technologies to market.”

The event attracted 265 dealmakers from 183 companies representing 21 countries. Delegates participated in 749 one-to-one meetings, a 25% increase over 2013. The event also featured presentations by 27 of the most exciting international medtech companies.

“More than 250 delegates from national as well as international medtech companies followed our invitation and benefited from the partnering conference. More than 700 pre-organized meetings with potential business partners facilitated the networking among the participants and laid ground for future projects,” said Michael Strugl, Minister of Economy, State Government of Upper Austria, drawing balance for Upper Austria and its emerging medtech companies.

EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors.

Produced by EBD Group, EuroMedtech caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as drug delivery and augmented intervention in medicine, through diagnostics, imaging and eHealth to those involved in platform technologies such as micro and nanotechnological tools and implantable devices.

Video coverage from EuroMedtech 2014 is available on partnering360®.

Medtech industry leaders are encouraged to continue their partnering activities by joining the partnering360® Medtech Industry Group. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of medtech companies on partnering360 today.

Or follow EuroMedtech on Twitter: @EuroMedtech, hashtag #EMT14.

About the Health Technology Cluster

The Health Technology Cluster (HC) is an inter-sectoral network for increasing innovative capacity and international competitiveness of Health Technology companies, their suppliers as well as relevant research and healthcare facilities. The HC currently connect 220 partner companies from Austria and South Germany. Due to the Upper Austrian strength in medical technology, the main focus is on medical electronics, software, clean room & hygiene, hospital equipment, end-user products, diagnostics-pharma and materials (metal/plastics). More detailed information under www.gesundheitstechnologie-cluster.at.

Please find the digital version under www.gesundheitstechnologie-cluster.at/presse

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

Contacts

EBD Group
Erin Righetti, +1 760 930 0500
erighetti@ebdgroup.com
or
Media-Contact:
Communication Health Technology Cluster (Clusterland Oberösterreich GmbH)
Stephanie Rieß, M.A.
+43 732 79810 5158
stephanie.riess@clusterland.at


Source: EBD Group

Smart Multimedia Gallery

EuroMedtech(TM) 2014 (Photo: Business Wire)

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20140515005227/en